The Other Side of the Uber Litigation: Why PI Firms Aren't the Villains

When a company with Uber's scale and legal resources files federal racketeering claims against personal injury firms and medical providers, the public narrative tends to arrive fully formed: a sophisticated fraud network has been exposed, and the firms named are villains gaming the system. But the Uber RICO litigation personal injury firms are now defending against deserves a more careful look than that framing allows. Contingency-fee representation, medical lien billing, and the economics of rideshare insurance are all genuinely complicated subjects, and reducing them to an allegation of organized fraud skips over legitimate, longstanding practices that have functioned as the backbone of access to justice for injured people who could never otherwise afford a lawyer. This piece lays out the other side of that story.

Access to Justice and the Role of Contingency Fees

Access to justice and contingency fee representation are inseparable in the personal injury context. Most people injured in a rideshare accident don't have the resources to pay a lawyer by the hour, cover expert witness fees, or front the cost of litigation against a company with virtually unlimited legal resources. The contingency fee model exists precisely to close that gap: an attorney takes on the financial risk of a case, invests in building it properly, and gets paid only if the case succeeds. This arrangement is not a loophole or a workaround, it is a deliberate and long-established feature of the American civil justice system, one that allows ordinary injured people to stand on something closer to equal footing against large, well-resourced defendants and their insurers. Framing the financial infrastructure that makes this possible, medical liens, case cost advances, and the referral relationships that support them, as inherently suspicious risks undermining the very mechanism that gives injured people a meaningful path to recovery.

Understanding SB 371 and Rideshare Insurance Coverage

SB 371 rideshare insurance coverage limits are central to understanding why claims costs associated with rideshare accidents look the way they do. California's tiered insurance framework for transportation network companies requires different coverage levels depending on whether a driver is logged into the app and waiting for a match versus actively transporting a passenger, and critics of the current system have long argued that coverage during the “waiting” period is thinner than it should be given the actual risk exposure on the road. When coverage limits are lower than the real cost of a serious injury, injured parties and their attorneys are left navigating a gap between what insurance actually pays and what a genuine injury actually costs, a gap that has nothing to do with fraud and everything to do with a regulatory framework that hasn't necessarily kept pace with the scale of the rideshare industry.

Medical Liens: A Legitimate Tool, Not a Conspiracy

Medical lien-based treatment billing practices sit at the heart of Uber's fraud allegations, but liens themselves are a well-established, entirely legal mechanism used across personal injury law, not a scheme invented to inflate claims. A medical lien allows an injured person without health insurance, or without coverage that will pay for accident-related treatment, to receive care immediately, with the provider agreeing to be paid out of any eventual settlement rather than demanding payment up front. Without this mechanism, many injured people, particularly those who are uninsured or underinsured, would simply go without needed treatment, worsening their medical outcomes and, ironically, making it harder to ever recover fair compensation for injuries that went undocumented and untreated. The existence of lien-based billing is not, by itself, evidence of anything improper; the relevant legal question in any specific case is whether the treatment provided was medically necessary and reasonably billed, not whether a lien was used as the payment mechanism.

Why Insurance Costs Have Genuinely Risen

Insurance fraud allegations against personal injury attorneys often skip past a simpler explanation for rising claims costs: medical care itself has become more expensive, vehicles have become more complex and costlier to repair, and jury verdicts across the country have generally trended upward over time as juries increasingly recognize the real, lasting cost of serious injuries. These are broad economic and social trends affecting the entire insurance industry, not evidence of coordinated fraud by any particular set of law firms. Attributing an entire industry's rising cost structure to a handful of allegedly bad actors, rather than acknowledging these larger economic forces, is a convenient narrative for a company facing mounting claims costs, but it isn't necessarily an accurate one, and it deserves scrutiny rather than uncritical acceptance.

• Medical treatment costs have risen substantially across the healthcare industry generally, not just in accident-related care
• Vehicle repair costs have increased with the complexity of modern vehicle technology and safety systems
• Jury awards have trended upward as courts increasingly recognize the full scope of injury-related harm
• Rideshare accident volume has grown substantially alongside the industry's overall growth
• Coverage gaps tied to tiered insurance structures shift real costs onto injured parties and their attorneys

The Power Imbalance Between Uber and Individual Claimants

It's worth stepping back to consider the scale mismatch at play in this litigation. Uber is a global company with enormous legal and financial resources, facing individual claimants who are, in nearly every case, ordinary people who were injured through no fault of their own. Personal injury firms exist specifically to correct that imbalance, pooling resources and expertise so that an injured passenger or pedestrian isn't forced to negotiate alone against a corporate legal department. Painting the firms that perform this function as the villains of the story, rather than acknowledging the fundamental power imbalance between a multinational corporation and an injured individual, inverts who actually holds the leverage in these disputes. Skepticism toward large-scale litigation against corporate defendants is healthy and appropriate in specific cases with specific evidence, but skepticism applied as a blanket indictment of an entire practice area serves the interests of the party with by far the greater resources.

How Standardized Treatment Protocols Get Misread

One of the more misunderstood aspects of this debate involves standardized initial treatment protocols, the fact that many patients presenting with similar accident mechanisms, a rear-end collision causing whiplash, for instance, receive broadly similar initial evaluations and conservative treatment recommendations. Critics point to this consistency as evidence of a manufactured pipeline. But medicine itself relies heavily on standardized protocols for common presentations; that's simply how evidence-based care works. A physician evaluating a patient with classic whiplash symptoms following a rear-end collision reasonably starts with a well-established, conservative treatment pathway, not because of a coordinated scheme, but because that pathway reflects accepted clinical practice for that type of injury. Treating protocol consistency as inherently suspicious ignores how modern, evidence-based medicine actually operates across virtually every specialty, not just in accident-related care.

The Chilling Effect on Injured Claimants

There's a less-discussed consequence of this kind of high-profile litigation: its chilling effect on injured people who have entirely legitimate claims. When a company with Uber's public profile files sweeping fraud allegations against the personal injury bar, media coverage tends to paint the entire practice area with the same brush, and injured people considering whether to pursue a legitimate claim may absorb a message that hiring an attorney or accepting lien-based treatment makes them part of something suspect. This dynamic serves corporate defendants well, regardless of the merits of any individual case, because a chilled claimant is a claimant less likely to pursue full and fair compensation. Advocates for injured people have raised this concern directly: aggressive, headline-grabbing litigation against an entire practice model can suppress legitimate claims just as effectively as it deters any actual fraud, arguably more so, since genuine bad actors are a small fraction of the practicing bar while the population of legitimately injured claimants is vastly larger.

Comparing the Two Narratives

It's useful to lay the competing narratives side by side, since the underlying facts, rising claims costs, lien-based billing, referral relationships, and standardized treatment, are the same in both accounts. What differs is the interpretation applied to those facts.

Where Legitimate Concerns Do Exist

None of this is to say the personal injury industry is beyond legitimate criticism. Like any industry built around high case volume, there are bad actors, firms and providers that do cross ethical or legal lines, that do inflate treatment beyond genuine medical necessity, or that do structure referral relationships in ways that prioritize revenue over client welfare. Those practices deserve scrutiny and, where they exist, consequences. The distinction that matters is between individualized enforcement against specific bad actors, based on specific evidence, and a sweeping RICO theory that risks treating an entire, longstanding, and largely legitimate practice model, contingency representation supported by medical liens, as inherently criminal. The former protects the integrity of the system; the latter threatens to dismantle access to justice for the overwhelming majority of injured people whose claims and treatment are entirely legitimate.

The Historical Pattern of Industry-Wide Litigation Against Plaintiffs' Firms

This isn't the first time a well-resourced industry has responded to rising claims costs by attacking the plaintiffs' bar broadly rather than addressing underlying cost drivers directly. Insurance-adjacent industries have periodically pursued similar strategies against personal injury practice as a whole, whether through legislative lobbying for damage caps, public relations campaigns characterizing plaintiffs' attorneys as opportunistic, or litigation aimed at referral and billing practices that are common across the industry rather than isolated to specific bad actors. Viewed against this historical pattern, the Uber RICO litigation looks less like an unprecedented discovery of criminal conduct and more like the latest iteration of a familiar playbook: when claims costs rise, target the mechanism that allows injured people to bring claims in the first place, rather than the underlying cost drivers of medical care, vehicle repair, or the risk exposure inherent in the business model itself.

What This Means for Attorneys Practicing in Good Faith

For the vast majority of personal injury attorneys who build their practice around legitimate, well-documented claims, this litigation presents a frustrating dynamic: having to defend a practice model that has served injured clients well for decades, against allegations aimed at what appears to be a narrower set of actual bad actors. The practical response many firms have adopted, tightening documentation, diversifying provider relationships, and ensuring clinical independence is well-recorded, is worth pursuing regardless of one's view on the merits of Uber's specific claims, since good documentation protects both the firm and the client's interests either way. But that practical response shouldn't be confused with an admission that contingency representation, medical liens, or attorney-provider referral relationships are themselves improper. They remain legitimate, necessary tools for delivering access to justice to people who would otherwise have none.

What a Fair Resolution Would Look Like

A fair resolution to this litigation, and to the broader public conversation it has sparked, would separate genuine fraud from the ordinary mechanics of contingency-fee personal injury practice. That means courts scrutinizing the actual evidence against actual defendants rather than treating an entire billing and referral model as presumptively suspect. It means recognizing that medical liens, referral relationships between attorneys and treating providers, and standardized initial treatment protocols for common accident injuries are not, by themselves, evidence of a criminal enterprise, they are the normal infrastructure of an industry built to give injured people a path to both medical care and legal recourse they could not otherwise afford. And it means acknowledging that rising claims costs reflect real economic and legal trends across the entire industry, not a conspiracy confined to a handful of firms that happen to have drawn a well-resourced corporate defendant's attention.

The Uber RICO litigation raises real questions worth taking seriously, and any genuine fraud uncovered in the process should be addressed through the legal system exactly as the law intends. But the sweeping narrative that personal injury firms broadly operate as a coordinated criminal enterprise deserves the same scrutiny as the allegations themselves. Contingency-fee representation and medical lien billing exist because, without them, a huge share of injured people would have no meaningful way to pursue fair compensation against well-resourced corporate defendants. That access to justice function is worth defending, even, and perhaps especially, while individual allegations of genuine misconduct are sorted out in court.